AMBER SHELL: Open Payments
NPI 1104348812 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,411 in 147 payments from 16 companies in 2025. Trend: 2023 $1,292 · 2024 $1,920 · 2025 $3,411
Food & beverage: $3,411
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $1,095 |
| Janssen Biotech, Inc. | 15 | $402 |
| Madrigal Pharmaceuticals | 13 | $321 |
| Phathom Pharmaceuticals, Inc. | 11 | $282 |
| Aimmune Therapeutics, Inc. | 10 | $253 |
| Gilead Sciences, Inc. | 6 | $182 |
| Ardelyx, Inc. | 8 | $165 |
| Regeneron Healthcare Solutions, Inc. | 6 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $138 |
| GENZYME CORPORATION | 2 | $127 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, VOQUEZNA, DUPIXENT, ZENPEP, IBSRELA, MAVYRET.
Industry payments across AL — which companies pay providers there.
